Therapeutic Drug Monitoring Service

Expert consultation service for optimization of drug dosing through therapeutic drug monitoring. Provides pharmacokinetic analysis and clinical guidance for complex polypharmacy management.

Comprehensive genetic testing service supporting precision drug therapy and personalized medicine applications. Integrates molecular analysis with therapeutic drug monitoring for comprehensive patient profiling.

Analytical and functional testing of pharmaceutical drug delivery devices and systems. This service validates device performance and drug delivery accuracy.

Laboratory analysis service for medical device quality, safety, and microbiological validation. This service ensures compliance with ISO 13485 and regulatory requirements.

Water quality analysis service for medical device manufacturing and processing. Ensures compliance with pharmaceutical and medical device quality standards.

In-house diagnostic service for testing and analyzing patient sera samples. Provided by Bio-Diagnostics own private laboratory with NEQAS participation.

Chemical analysis and testing service for medical device materials and components to ensure safety and compliance. Performed by accredited laboratory following international quality standards.

Comprehensive precision medicine solutions covering over 2000 service items across oncology, maternal-child health, cardiovascular, and infectious diseases. Services include disease screening, early diagnosis, molecular profiling, drug sensitivity selection, efficacy monitoring, and prognosis assessment.

Expert regulatory support for medical device approval including MDR and FDA compliance guidance. Provides data-driven safety dossiers and toxicological risk assessments to accelerate time-to-market globally.

Third-party testing service for microbiological analysis of medical devices, including sterility assurance and bioburden testing. Conducted according to ISO/IEC 17025 standards with CMA and CNAS certification.

Comprehensive analytical and clinical performance evaluation studies for diagnostic assays with CE marking support.

A personalized testing service using patient-derived organoids to evaluate drug efficacy and identify optimal therapeutic candidates for individual cancer treatment protocols.